CTNI-52. RETROSPECTIVE ANALYSIS OF USING RADIOTHERAPY WITH CONCURRENT TEMOZOLOMIDE AND TUMOR TREATING FIELDS FOR CHINESE PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
Yang Wang(Fudan University), Chao Li(Obstetrics and Gynecology Hospital of Fudan University), peijiang Lu(Fudan University), Chunxia Ni, Dongxiao Zhuang(Shanghai Center for Brain Science and Brain-Inspired Technology), Enmin Wang(Fudan University), Shu Chen(Dalian Medical University), Jingsong Wu(Fudan University), Yu Yao(Qinghai University), Zhiyong Qin(Huashan Hospital), Lipin Liang(Fudan University)
Cited by 1
Related Papers
CGCG clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2016|650
Clinical practice guidelines for the management of adult diffuse gliomas
|Cancer Letters|2020|482
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis
|The Lancet Oncology|2016|374
Temozolomide-associated hypermutation in gliomas
|Neuro-Oncology|2018|227
Adult IDH wild-type lower-grade gliomas should be further stratified
|Neuro-Oncology|2017|222